
Insider and congress filings
Hims & Hers Health, Inc. (HIMS)
NYSE · Healthcare · 346 insider filings · 2 congress trades · last filed 8 days ago
About Hims & Hers Health, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Andrew Dudum
- Employees
- 2,442
- Listed since
- -
- Market value
- $6.2B
- Price to earnings
- -
- Earnings per share
- -$0.61
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 9, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 10, 2026 | -$0.37 | -$0.05 | $753.2M | $698.9M | EPS missRevenue beat |
| Q1 FY2026reported May 11, 2026 | -$0.40 | $0.03 | $608.1M | $616.8M | EPS missRevenue in line |
| Q4 FY2025reported Feb 23, 2026 | $0.07 | $0.02 | $617.8M | $619.2M | EPS beatRevenue in line |
| Q3 FY2025reported Nov 3, 2025 | $0.06 | $0.09 | $599.0M | $618.1M | EPS missRevenue miss |
| Q2 FY2025reported Aug 4, 2025 | $0.17 | $0.18 | $544.8M | $584.1M | EPS missRevenue miss |
| Q1 FY2025reported May 5, 2025 | $0.20 | $0.12 | $586.0M | $538.6M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 28, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Mr. ElshenawyChief Technology Officer | $375K | $57.2M | $3.3M | $60.9M |
| Mr. DudumChief Executive Officer and Chairman | $495K | $10.6M | $11.8M | $23.0M |
| Mr. OkupeChief Financial Officer | $531K | $7.5M | $394K | $8.4M |
| Mr. ChiChief Operating Officer (previously Chief Commercial O | $485K | $6.9M | $344K | $7.7M |
| Ms. BoughtonChief Legal Officer | $464K | $4.0M | $308K | $4.8M |
The summary compensation table from the 2025 proxy statement, current executives only. 2 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $995.2M | 28,703,514 | +9.0% | 12.39% |
| Susquehanna International Group, LLP | $469.4M | 13,539,700 | +5.4% | 5.84% |
| Vanguard Portfolio Management LLC | $366.1M | 10,559,314 | +3.7% | 4.56% |
| Vanguard Capital Management LLC | $330.8M | 9,541,384 | +2.2% | 4.12% |
| Susquehanna International Group, LLP | $312.2M | 9,004,900 | -14.8% | 3.89% |
| State Street Corp | $282.4M | 8,145,699 | +9.2% | 3.51% |
| Morgan Stanley | $248.0M | 7,152,498 | -19.5% | 3.09% |
| Citadel Advisors LLC | $210.4M | 6,067,800 | -12.3% | 2.62% |
| Divisadero Street Capital Management, LP | $208.3M | 6,009,505 | +1179.1% | 2.59% |
| Geode Capital Management, LLC | $197.0M | 5,681,832 | +9.3% | 2.45% |
| Goldman Sachs Group Inc | $179.4M | 5,173,865 | +110.8% | 2.23% |
| Jane Street Group, LLC | $173.0M | 4,990,600 | -39.7% | 2.15% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Open-market insider trades
10 filings of 346 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Soleil BoughtonChief Legal Officer | Sold · scheduled | 3,458 | $28.33 | $98K | Sep 2, 2026 | 1d |
| Oluyemi OkupeChief Financial Officer | Sold | 4,938 | $29.99 | $148K | Aug 19, 2026 | 1d |
| Deborah M. AutorChief Policy Officer | Sold | 16,773 | $27.85 | $467K | Aug 18, 2026 | 2d |
| Soleil BoughtonChief Legal Officer | Sold | 25,111 | $27.55 | $692K | Aug 19, 2026 | 1d |
| Oluyemi OkupeChief Financial Officer | Sold | 9,388 | $27.89 | $262K | Aug 17, 2026 | 1d |
| Oluyemi OkupeChief Financial Officer | Sold | 55,383 | $35.09 | $1.9M | Jun 18, 2026 | 61d |
| Oluyemi OkupeChief Financial Officer | Sold | 7,163 | $31.99 | $229K | Jul 17, 2026 | 3d |
| Oluyemi OkupeChief Financial Officer | Sold | 7,163 | $36.49 | $261K | Jul 6, 2026 | 1d |
| Patrick Harrison CarrollChief Medical Officer | Sold | 23,726 | $35.00 | $830K | Jun 18, 2026 | 5d |
| Oluyemi OkupeChief Financial Officer | Sold | 18,197 | $34.03 | $619K | Jun 22, 2026 | 1d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in HIMS
2 disclosures of 2 on record · median 39d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Tony Wied | Stock | Purchase | $500,001 - $1,000,000 | +9.2%S&P +10.5% · vs S&P 500 -1.3% | Feb 3, 2026 | Mar 9, 2026 | 34d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | -56.7%S&P +21.0% · vs S&P 500 -77.7% | Aug 4, 2025 | Sep 12, 2025 | 39d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
1 member · estimate, as of Sep 10, 20261 member reports a position (estimated). The largest estimated position is in the $500,001 - $1,000,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Tony Wied | Republican · House | $500,001 - $1,000,000 | 3.5% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Andrew DudumChief Executive Officer | Other (see filing) | 977,566 | Aug 27, 2026 |
| Andrew DudumChief Executive Officer | Gift | 463,289 | Aug 25, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercise | 4,938 | Aug 19, 2026 |
| Patrick Harrison CarrollChief Medical Officer | Option exercise | 52,114 | Aug 14, 2026 |
| Andrew DudumChief Executive Officer | Option exercise | 309,986 | Aug 14, 2026 |
| Kare SchultzDirector | Option exercise | 6,623 | Aug 14, 2026 |
| Michael ChiChief Operating Officer | Option exercise | 172,530 | Aug 14, 2026 |
| Andrew DudumChief Executive Officer | Tax withholding | 78,859 | Aug 14, 2026 |
| Soleil BoughtonChief Legal Officer | Option exercise | 84,522 | Aug 14, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercise | 143,232 | Aug 14, 2026 |
| Oluyemi OkupeChief Financial Officer | Option exercise | 9,388 | Aug 17, 2026 |
| Deborah M. AutorChief Policy Officer | Tax withholding | 16,147 | Aug 14, 2026 |
| Patrick Harrison CarrollChief Medical Officer | Tax withholding | 10,201 | Aug 14, 2026 |
| Deborah M. AutorChief Policy Officer | Option exercise | 32,920 | Aug 14, 2026 |
| Soleil BoughtonChief Legal Officer | Tax withholding | 21,500 | Aug 14, 2026 |
| Oluyemi OkupeChief Financial Officer | Tax withholding | 36,437 | Aug 14, 2026 |
| Michael ChiChief Operating Officer | Tax withholding | 47,702 | Aug 14, 2026 |
| Irene BecklundPAO | Option exercise | 27,370 | Aug 14, 2026 |
| Christopher D. PayneDirector | Option exercise | 545 | Aug 14, 2026 |
| Irene BecklundPAO | Tax withholding | 6,490 | Aug 14, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling HIMS?
Across the 10 most recent open-market filings shown here, 0 were purchases and 10 were sales. One was scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded HIMS?
Tony Wied, Lisa C. McClain disclosed HIMS transactions in the filings shown here.
Which members of Congress hold HIMS?
1 member of Congress reports a position in HIMS in the estimate we hold as of Sep 10, 2026. The largest estimated position belongs to Tony Wied. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are HIMS trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 39 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
